Sanofi-Aventis (SNY) Joins The 52-Week Low Club
The market rally thinned out the membership a bit. Melco PBL (MPEL) Casino company still fighting concerns that Chinese government will restrict travel to Macau. Drops to $12.01 from 52-week high of $23.55. Diversa (DVSA) Developer of specialty enzymes recently…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The market rally thinned out the membership a bit.
Melco PBL (MPEL) Casino company still fighting concerns that Chinese government will restrict travel to Macau. Drops to $12.01 from 52-week high of $23.55.
Diversa (DVSA) Developer of specialty enzymes recently amended a promissory note. Shares down to $5.22 from 52-week high of $12.44.
Mylan Labs (MYL) Recently bought generics business of Merck KGaA. Drops to $18.37 from 52-week high of $23.49.
Sanofi-Aventis (SNY) FDA turned down marketing of its major diet drug due to health concerns. Drops to $41.09 from 52-week high of $50.05.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.